Allogeneic stem cell transplantation for chronic myeloid leukemia

被引：41

作者：

Barrett, J ^{[1
]}

机构：

[1] NHLBI, Stem Cell Allotransplantat Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 01期

关键词：

D O I：

10.1053/shem.2003.50003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 71

页数：13

共 98 条

[41]

HOROWITZ MM, 2002, IBMTR ABMTR NEWSLETT, V9, P4

[42] Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation [J].

Jiang, YZ ;

Barrett, AJ ;

Goldman, JM ;

Mavroudis, DA .

ANNALS OF HEMATOLOGY, 1997, 74 (01) :1-6

[43] Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia [J].

Kaeda, J ;

Chase, A ;

Goldman, JM .

ACTA HAEMATOLOGICA, 2002, 107 (02) :64-75

[44] Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans [J].

Kim, I ;

Park, S ;

Kim, BK ;

Chang, HM ;

Bang, SM ;

Byun, JH ;

Kim, DJ ;

Min, WS ;

Kim, HJ ;

Kim, CC .

CLINICAL TRANSPLANTATION, 2001, 15 (03) :167-172

[45] Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission [J].

Kitzis, A ;

Brizard, F ;

Dascalescu, C ;

Chomel, JC ;

Guilhot, F ;

Brizard, A .

LEUKEMIA & LYMPHOMA, 2001, 42 (05) :933-+

[46] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].

KOLB, HJ ;

SCHATTENBERG, A ;

GOLDMAN, JM ;

HERTENSTEIN, B ;

JACOBSEN, N ;

ARCESE, W ;

LJUNGMAN, P ;

FERRANT, A ;

VERDONCK, L ;

NIEDERWIESER, D ;

VANRHEE, F ;

MITTERMUELLER, J ;

DEWITTE, T ;

HOLLER, E ;

ANSARI, H .

BLOOD, 1995, 86 (05) :2041-2050

[47] DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS [J].

KOLB, HJ ;

MITTERMULLER, J ;

CLEMM, C ;

HOLLER, E ;

LEDDEROSE, G ;

BREHM, G ;

HEIM, M ;

WILMANNS, W .

BLOOD, 1990, 76 (12) :2462-2465

[48] Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia [J].

Konstantinidou, P ;

Szydlo, RM ;

Chase, A ;

Goldman, JM .

BONE MARROW TRANSPLANTATION, 2000, 25 (02) :143-146

[49] Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients [J].

Kröger, N ;

Zabelina, T ;

Krüger, W ;

Renges, H ;

Stute, N ;

Kabisch, H ;

Jaburg, N ;

Löliger, C ;

Krüll, A ;

Zander, AR .

BONE MARROW TRANSPLANTATION, 2001, 27 (04) :349-354

[50] The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase [J].

Lee, SJ ;

Klein, JP ;

Anasetti, C ;

Antin, JH ;

Loberiza, FR ;

Bowell, BJ ;

LeMaistre, CF ;

Litzow, MR ;

Marks, D ;

Waller, EK ;

Matlack, M ;

Giralt, S ;

Horowitz, MM .

BLOOD, 2001, 98 (12) :3205-3211

← 1 2 3 4 5 6 7 8 9 10 →